Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any sex.
- People who have cirrhosis, or who meet the medical guidelines for regular liver cancer (HCC) monitoring.
- People who have been clinically diagnosed with liver cancer (HCC), or people who have been checked and found not to have liver cancer.
- Liver cancer (HCC) group: People with a recent liver cancer diagnosis (within the last 6 months) that has not yet been treated, confirmed by a scan or biopsy showing at least one tumour of a certain size and appearance.
- No liver cancer group: People with chronic liver disease who are having routine scans to monitor for liver cancer, and who have had a confirmed clear result within the past 3 months — either by CT or MRI scan, or by ultrasound.
Who may not be able to join:
- People who are unwilling or unable to sign a consent form.
- People who have been diagnosed with another type of cancer (other than certain common skin cancers) within the past 5 years.
- People who have had chemotherapy or radiation treatment within the past 5 years.
- People who have previously been treated with specific drugs used for liver cancer, including sorafenib or regorafenib.
- People who have previously been treated with certain medicines that affect DNA, such as azacitidine (Vidaza) or decitabine (Dacogen).
- People who have had any liver cancer treatment before enrolment, such as surgery, ablation, chemotherapy, radiation, or a liver transplant.
- People who have had contrast dye used in a CT or MRI scan within 24 hours before the blood sample is collected.
- People who have had a fine needle biopsy of the relevant area within 3 days before blood collection.
- People who have had any other type of biopsy of the relevant area within 7 days before blood collection.
- People whose condition, in the opinion of the trial doctor, might affect their ability to consent, follow the study procedures, or their safety during the trial.
- People in the "no liver cancer" group who have previously been diagnosed with liver cancer at any time.
- People who are pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Taggert, Helio Health
Phone: 626-350-0537
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Independent performance measure of sensitivity and specificity of a multi-analyte blood test
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.